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samples from Helsinki were also positive by PCR.
One tissue sample (2–3 mg) was toxoplasma
DNA-positive in Helsinki, but negative in the
present study, again probably because of lack of
sufficient sample material. The sample volume is
important for a reproducible result. A minimum
of 2 mL of liquid sample or 10 mg of solid sample
was found to yield a reproducible result.
The lengths of the T. gondii-specific PCR prod-
uct (469 bp) and the b-globin inhibition control
(PCR) product (140 bp) were different. The effect
of this product-length difference on the PCR was
tested in a series of experiments, but no influence
on specificity or sensitivity was detected. In
addition, it was observed that the b-globin prim-
ers were capable of amplifying a specific PCR
product at annealing temperatures ranging from
48C to 64C.
It was concluded that the PCR method was a
rapid and sensitive approach to detecting T. gondii
DNA directly from clinical samples. Quantifica-
tion of DNA with real-time PCR experiments is
being used increasingly for the detection and
follow-up of various infections, and it would be
interesting to study the use of quantitative real-
time PCR for detection of T. gondii.
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ABSTRACT
This study evaluated the possible advantages
provided by a genotypic method over commer-
cially available biochemical systems for the iden-
tification of clinical isolates of coagulase-negative
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staphylococci (CNS). Partial sequencing of the
sodA gene was performed for 168 coagulase-
negative clinical isolates of staphylococci identi-
fied previously with the ID32 STAPH system. Of
these, 101 (60.1%) were identified to the species
level with ID32 STAPH, while 67 (39.9%) were
misidentified or not identified with certainty.
Sequencing of sodA proved useful for resolving
all ambiguities or inconclusive identifications
generated by the commercially available bio-
chemical identification system.
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Coagulase-negative staphylococci (CNS) are ubi-
quitous commensals of human skin and mucous
membranes, and have emerged in recent years as
some of the most important pathogens involved in
nosocomial infections [1]. Commercial systems
based on biochemical reactions are used routinely
for the identification of staphylococci in clinical
samples, but such systems may lead to misiden-
tification or fail to yield a result because of the
variable expression of metabolic pathways or
interpretation of results. One of the systems used
most widely is the ID32 STAPH system (bio-
Me´rieux, Marcy-l’Etoile, France), but its perform-
ance with clinical strains has not been evaluated in
comparison with recently developed genotypic
methods. In addition to genotypic methods for the
identification of CNS, such as internal transcribed
spacer (ITS)-PCR [2], ribotyping [3] or real-time
PCR [4], PCR-based sequencing methods allow
objective and discriminating identification of
staphylococci by analysis of the partial sequences
of genes such as hsp60 [5], rpoB [6] and sodA [7],
and also allow recognition of previously unre-
ported sequences from novel species.
Few studies have evaluated the possible
advantages provided by genotypic identification
in comparison with routine laboratory methods.
To approach this question, identification data
obtained routinely with the ID32 STAPH system
were assessed in comparison with sodAint sequen-
cing [7]. In total, 168 coagulase-negative staphy-
lococci collected between January 1999 and
September 2002 were studied, including 85 clin-
ical isolates and 83 isolates from hand-skin swabs
(45 isolates from 30 healthy volunteers, and 38
isolates from 29 patients attending the hospital).
Multiple isolates from the same source were
included if they had differences in colony mor-
phology after incubation for 48 h on sheep blood
agar and a different antibiotic susceptibility pat-
tern (at least one different resistance marker). All
isolates were cryo-preserved after initial culture.
Frozen isolates were subcultured once on sheep
blood agar before their identification by ID32
STAPH or sodAint sequencing. Conventional
phenotypic identification tests included Gram’s
stain, catalase test, Slidex latex agglutination test
(bioMe´rieux) and tube coagulase test. ID32
STAPH tests were performed according to the
manufacturer’s recommendations. Profiles were
read visually and interpreted with MINIAPI
software (ID32 STAPH v.2.0; bioMe´rieux).
Identification by sodAint sequencing was per-
formed as follows. Sheep blood agar cultures
were resuspended in sterile distilled water (5·
McFarland standard). DNA was extracted by
boiling and centrifugation, or with a DNAeasy
tissue kit (Qiagen, Courtabœuf, France) used
according to the manufacturer’s protocol for
Gram-positive bacteria. Amplification of sodAint
was as described previously [7] using primers d1
(5¢-CCITAYICITAYGAYGCIYTIGARCC-3¢) and
d2 (5¢-ARRTARTAIGCRTGYTCCCAIACRTC-3¢).
Sequencing reactions were analysed on an ABI
310 (Applied Biosystems, Courtabœuf, France) or
a MegaBACE 500 (Amersham Biosciences, Frei-
burg, Germany) system with the BioEdit software
program [8]. Sequences were compared [9]
against a local database of sodAint gene sequences
from Staphylococcus type strains [7]. Identification
to the species level was based on sequence
identity with the type strain sequence of ‡ 97%
and a difference in sequence identity from the
next closest species of ‡ 5%. These criteria
allowed discrimination of the closest species with
two exceptions: S. condimenti and S. carnosus
(96.7% nucleotide identity), and S. condimenti
and S. piscifermentans (95.6% nucleotide identity);
however, these species are isolated infrequently
from clinical sources. S. vitulinus and S. pulvereri
were indistinguishable, which is consistent with
the hypothesis that these two organisms are a
single species [10].
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The sodAint fragment was amplified efficiently
and sequenced on both strands from all 168
isolates. All PCRs were initially carried out on
DNA extracted by boiling, which allowed the
amplification of sodAint fragments from 138 iso-
lates. The 30 remaining isolates (S. epidermidis,
12 ⁄ 87; S. capitis, 7 ⁄ 16; S. simulans, 3 ⁄ 4; S. hominis,
2 ⁄ 23; S. lugdunensis, 2 ⁄ 7; S. caprae, 1 ⁄ 3; S. haemo-
lyticus, 1 ⁄ 7; S. pasteuri, 1 ⁄ 6; S. warneri, 1 ⁄ 13) were
amplified after DNA purification with the DNA-
easy tissue kit. The sodAint sequences revealed a
maximum intra-specific variation of 1.7% for
S. epidermidis when compared to the type strain
sequences (excluding both sub-species of S. cohnii,
which differ by as much as 4%). The dataset
displayed no overlap between clusters of
sequences from the same species, and all 168
isolates were identified to the species level
(Table 1). To test the reliability of the process,
the raw sequences obtained with each primer
were analysed independently, always with the
same species assignment.
Partial sequencing of the sodA gene proved to
be a simple and effective method for the identi-
fication of Staphylococcus species. The results of
ID32 STAPH vs. sodAint identification are shown
in Table 1. In comparison with sodAint, ID32
STAPH identified 101 of the 168 isolates (60.1%)
to the taxon or species level, with > 80% ‘accept-
able’ or better identification. Of the remaining
67 isolates, 60 (35.7%) were identified unsatisfac-
torily (low discrimination, uncertain identifica-
tion, unacceptable identification, or identification
to the genus level only), while seven (4.2%) were
misidentified. Misidentifications included two
isolates of S. hominis (one identified as Kocuria
sp. and one as S. warneri), one isolate of S. capitis
(identified as S. caprae) and four isolates of
S. pasteuri (three identified as S. warneri—pheno-
typically the most similar species [11]—and one
as S. hominis). Misidentification occurred five
times out of seven with a ‘very good’ or better
erroneous rating.
Thus, nearly a third of the isolates were not
identified to the species level with the ID32
STAPH system, compared to the 2.98% claimed
by the manufacturer. Results reported in the
literature range from 3% to 47.6% [7,12–15], but
these differences may be accounted for by
species bias in collections. Indeed, the accuracy
of the ID32 STAPH system clearly varies accord-
ing to coagulase-negative staphylococcus species
[12,14]. In the present study, the ID32 STAPH
system provided species-level identification for
61 (70.1%) of 87 S epidermidis isolates, but for
only three (13%) of 23 S hominis isolates. Mis-
identifications were infrequent in the present
series and involved mainly S. pasteuri. This
problem has been reported previously, and
results from the absence of S. pasteuri from the
ID32 STAPH database. However, it is unfortu-
nate that these profiles usually result in false
rather than ambiguous identification [7,11] (this
study).
The ID32 STAPH system generated accurate
identifications for S. epidermidis, but the number
of isolates belonging to species other than
S. epidermidis was too limited to be conclusive.
In our routine practice, only ‘acceptable’ or better
MINIAPI software identification results for
S. epidermidis are validated. For other coagulase-
negative staphylococci, identification to the spe-
cies level relies on sodAint sequencing. The same
strategy could be used by any laboratory wish-
ing to improve their identification of coagulase-
negative staphylococcus species.
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Table 1. Comparison of identification results obtained by
the ID 32 STAPH system with those obtained by sodAint
sequencing
sodAint identification
ID32 STAPH identificationa
Satisfactory
identificationb
Unsatisfactory
identificationc Misidentificationd
S. capitis (n = 16) 11 4 1
S. caprae (n = 3) 2 1 0
S. cohnii (n = 2) 1 1 0
S. epidermidis (n = 87) 61 (70.1%) 26 0
S. haemolyticus (n = 7) 4 3 0
S. hominis (n = 23) 3 18 2
S. lugdunensis (n = 7) 6 1 0
S. pasteuri (n = 6) 0 2 4
S. simulans (n = 4) 3 1 0
S. warneri (n = 13) 10 3 0
All species (n = 168) 101 (60.1%) 60 (35.7%) 7 (4.2%)
aNumber (%) of isolates.
bAcceptable-to-excellent identification to the species level (or to the taxon level for
S. epidermidis and S. hominis) confirmed by sodAint sequencing.
cLow discrimination, uncertain identification, unacceptable identification, or correct
identification to the genus level only.
dAcceptable-to-excellent identification to the species level, but found to be
erroneous in comparison with sodAint sequencing; see text for further details.
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ABSTRACT
A rapid method combining gyrA PCR–restriction
fragment length polymorphism analysis, parC
PCR and adonitol fermentation was developed
to identify Klebsiella pneumoniae phylogenetic
groups KpI, KpII and KpIII. Analysis of 420
clinical isolates from 26 hospitals showed that the
three groups were widespread geographically.
KpI comprised 80.3% of 305 isolates from blood
and 82.2–97.2% of isolates from other clinical
sources. KpIII was never found among isolates
from urinary tract infections. KpI isolates from
blood were generally less susceptible than KpIII
isolates to the ten antimicrobial agents tested,
with KpII being intermediate. The frequencies of
ceftazidime resistance were 21.6% and 8.6% in
KpI and KpIII isolates, respectively (p 0.01).
Keywords Epidemiology, identification, Klebsiella
pneumoniae, Klebsiella variicola, resistance
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Klebsiellae are opportunistic pathogens that cause
septicaemia, pneumonia, urinary tract infections
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